By December 2023, 12.3% of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM.

A new study has found that the weight-loss drug tirzepatide can help people lose a significant amount of weight and keep it ...

In this retrospective cohort study, tirzepatide dispensations were found to have increased significantly following approval ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

At week 40, the change from baseline in HbA1c was −1.44 and −0.67 percent with tirzepatide and dulaglutide escalation to 4.5 mg or maximum tolerated dose, respectively. HealthDay News — For patients ...

You’re looking at the new MG S5 EV, yet another new challenger in the increasingly busy B-segment SUV market and the fifth EV from the brand. It’ll ride on the same Modular Scalable Platform ...

Recent clinical research has demonstrated that the drug tirzepatide offers significant benefits for individuals suffering from obesity, chronic kidney disease, and heart failure with preserved ...

In one study, up to 50% of patients experienced gastrointestinal issues and other adverse effects after taking a 15-mg dose of tirzepatide. Many families have filed lawsuits against the makers of ...

Primary endpoint met in the 8-week treatment study (highly statistically significant). Co-administered group had a 4.4% reduction in weight compared to 1.6% for the placebo group (p<0.0001).

Primary analysis for the co-administered group in the 8-week treatment study showed: 40% of patients achieved 5% ... Low dose bremelanotide arm stopped weight regain seen post tirzepatide treatment.

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to ... the months to come,” said Vernon. While drug companies say they are working to lower ...